Louisiana Family Files Zofran (ondansetron) Lawsuit over Heart Defects
In one of the latest complaints filed against GlaxoSmithKline LLC over the anti-nausea drug Zofran (ondansetron), a family from Louisiana claims that the drug caused their two children to be born with heart defects. Zofran (ondansetron) was first approved by the FDA in 1991 for use in cancer patients undergoing chemotherapy or radiation therapy and …. Read More